-
Evonik Strengthens its Exclusive Synthesis Business in the USEssen,Germany-basedindustrialsgroupEvonikIndustriesAGhasagreedtoacquireIndianapolis,Indiana-basedEliLillyandCompany’sTippecanoeLaboratoriesmanufacturingfacilityinLafayette,Indiana.Thesite,whichemploys2009/11/10
-
Oncodesign to Develop Experimental Cancer Models for sanofi-aventisOncodesign,aspecialistintheidentificationofnovelcancertherapies,hassigneda2-yearservicecontractwithsanofi-aventisunderwhichitistosupplyanddevelopexclusive,experimentalmodelsindifferenttypesofcancerfor2009/11/10
-
Chemical Suppliers Grow By Helping Customers Reduce Costs, Shows Industry SurveyCMSproviderspartnerwithcustomerstomanagetheirentirechemicallifecycleandcreatesavingsbyleveragingpurchases AccordingtotheCMSIndustryReport2009,ChemicalManagementServices(CMS)providersreported30%revenue2009/11/9
-
Carlos RestrepoISP to increase prices on 1,4 Butanediol and derivatives, including: N-Methyl-2-Pyrrolidone (NMP), Gamma-Butyrolactone (BLO), and Tetrahydrofuran (THF) prices globally. Effective September 12009/9/18
-
Inside IPEC–Americas: Evaluating Excipient Stability12 Next » The International Pharmaceutical Ex-cipients Council (IPEC) is in the final stages of developing an Excipient Stability Program Guide to provide an alternative approach2009/9/18
-
A review of recent product innovations, policy developments, and growth prospects in the excipients market123 Next » (IMAGE: EMANUELE TARONI/GETTY IMAGES) Although constituting a relatively small value of the cost of manufacturing a drug, excipients play a vital role in the f2009/9/18
-
Good Distribution Practices for Pharmaceutical Excipients1234 Next » Good manufacturing practice (GMP) for pharmaceutical products is well established and incorporated in European Union regulations. And thanks to the International Confe2009/9/16